Hepatitis B-Associated Liver Cancer Burden in Asia, 1990-2021

Supplementary file 1 from a study by Xin-Jing Yang analyzes the disease burden of hepatitis B virus-associated liver cancer in Asia from 1990 to 2021. Data were obtained from the 2021 Global Burden of Disease study, covering incidence, prevalence, deaths, and disability-adjusted life years (DALYs) by age, sex, and country. The dataset was last updated on 2026-04-23.

Use Cases

• Analyzing temporal trends in liver cancer incidence and mortality based on the 1990-2021 time series.
• Comparing the relative disease burden across Asian countries and regions as described in the results.
• Modeling the impact of hepatitis B on disability-adjusted life years (DALYs) by age and sex groups.

Strengths

• Data spans a 31-year period from 1990 to 2021, providing a long-term view of trends.
• Includes multiple burden metrics: incidence, prevalence, deaths, and disability-adjusted life years (DALYs).
• Breakdowns are available by age, sex, and country within Asia.

Limitations

• The dataset is small (105.7 KB), suggesting limited scope or aggregated summary data.
• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.

Provenance

Source

Global Burden of Disease study (2021)

Collection Method

Data processing and graph construction were performed using RStudio and BioWinford; Joinpoint regression was used for trend analysis.

Time Range

1990 to 2021

Freshness

Last updated 2026-04-23 05:35:46; freshness should be verified.

Geography

Asia, with regional and country-level breakdowns